Title: Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran.
Journal: International clinical psychopharmacology 20060501
175131-60-9
105310-47-2
1706432-40-7
103887-32-7
134002-25-8
175131-61-0
1033605-25-2 | (1R,2R)-2-(Benzylamino)cyclopentanol | AA0085RK | MFCD09999250
89795-79-9 | Benzo[d]isothiazol-7-amine | AA0086S7 | MFCD01658891
89204-90-0 | Methyl 5-(4-fluorophenyl)oxazole-4-carboxylate | AA0088Q6 | MFCD09800994
885266-98-8 | 4-Bromo-2-chloro-6-(trifluoromethoxy)aniline | AA0089NM | MFCD08236694
887982-11-8 | 6-(3-Methoxyphenyl)picolinic acid | AA008AXG | MFCD06410067
88462-46-8 | Phosphonium, (8-carboxyoctyl)triphenyl-, bromide | AA008C8Z
87414-49-1 | Butyrolactone I | AA008DIG | MFCD03453074
87592-41-4 | 4-(Trans-4-ethylcyclohexyl)benzoic acid | AA008EM7 | MFCD06658176
853929-59-6 | 2-[4-[[3-(4-BROMOPHENYL)-1-OXO-2-ALLYL]AMINO]-3-FLUOROPHENYL]-5-BENZOXAZOLEACETIC ACID | AA008F9C | MFCD12828743
84892-43-3 | 4-(4-Bromophenyl)cyclohexanone | AA008FUJ | MFCD11111144